Determining the HPV vaccine schedule for a HIV-infected population in sub Saharan Africa, a commentary

about

Determining the HPV vaccine schedule for a HIV-infected population in sub Saharan Africa, a commentary

Item

http://www.wikidata.org/entity/Q56987144

description

article

@en

im August 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Determining the HPV vaccine sc ...... b Saharan Africa, a commentary

@en

Determining the HPV vaccine sc ...... b Saharan Africa, a commentary

@nl

type

Item

label

Determining the HPV vaccine sc ...... b Saharan Africa, a commentary

@en

Determining the HPV vaccine sc ...... b Saharan Africa, a commentary

@nl

prefLabel

Determining the HPV vaccine sc ...... b Saharan Africa, a commentary

@en

Determining the HPV vaccine sc ...... b Saharan Africa, a commentary

@nl

P1476

Determining the HPV vaccine sc ...... b Saharan Africa, a commentary

@en

P2093

Mbabazi Kariisa

http://www.w3.org/2001/XMLSchema#string

Rodolfo Rossi

http://www.w3.org/2001/XMLSchema#string

Sonia Menon

http://www.w3.org/2001/XMLSchema#string

P2860

Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins

Classification of papillomaviruses

Epidemiology of HPV Genotypes among HIV Positive Women in Kenya: A Systematic Review and Meta-Analysis.

Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA Trials.

Prior human papillomavirus-16/18 AS04-adjuvanted vaccination prevents recurrent high grade cervical intraepithelial neoplasia after definitive surgical therapy: Post-hoc analysis from a randomized controlled trial

Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis

Prevalence of intestinal parasitic infections and risk factors among schoolchildren at the University of Gondar Community School, Northwest Ethiopia: a cross-sectional study.

Immunogenicity and safety of the quadrivalent human papillomavirus vaccine in HIV-1-infected women.

Human papillomavirus vaccine: a boon or curse.

Early human papillomavirus testing predicts residual/recurrent disease after LEEP.

P2888

s12985-018-1039-y

P304

129

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12985-018-1039-Y

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Steven Callens

P577

2018-08-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1106153731

http://www.w3.org/2001/XMLSchema#string

P698

30115083

http://www.w3.org/2001/XMLSchema#string

P921

infectious disease

virology

P932

6097212

http://www.w3.org/2001/XMLSchema#string